Two Sigma Investments’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YF
ACP
QF
SCM
O
ACA
SL
KCA
Two Sigma Investments's WHWK Position: Q2 2026 in Review
Two Sigma Investments increased its Whitehawk Therapeutics (WHWK) stake by 8.5% in Q2 2026, buying an estimated $96.2K and bringing the position to 296,612 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3366.
Two Sigma Investments first reported a position in WHWK in Q2 2019 and has held it in 11 quarters since. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.
- Two Sigma Investments held 296,612 shares of Whitehawk Therapeutics worth $1.36M as of Q2 2026.
- Two Sigma Investments bought 23,130 Whitehawk Therapeutics shares in Q2 2026, an estimated $96.2K.
- Whitehawk Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #3366 holding.
- Two Sigma Investments first reported a position in Whitehawk Therapeutics in Q2 2019 and has held it in 11 quarters since.
- 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.